Cargando…
Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure
Objective: Immune checkpoints inhibitors are promising and wide-spread agents in anti-cancer therapy. However, despite their efficacy, these agents could cause cardiotoxicity, a rare but life-threatening event. In addition, there are still no well-described predictive factors for the development of...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792535/ https://www.ncbi.nlm.nih.gov/pubmed/35096992 http://dx.doi.org/10.3389/fcvm.2021.759972 |